Shanghai Medicilon Inc. (SHA:688202)

Shanghai Medicilon Revenue

Shanghai Medicilon had revenue of 364.64M CNY in the quarter ending March 31, 2026, with 36.52% growth. This brings the company's revenue in the last twelve months to 1.26B, up 20.59% year-over-year. In the year 2025, Shanghai Medicilon had annual revenue of 1.16B with 12.08% growth.

• Revenue (ttm): 1.26B
• Revenue Growth: +20.59%
• P/S Ratio: 6.78
• Revenue / Employee: 536.66K
• Employees: 1,717
• Market Cap: 8.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.16B	125.32M	12.08%
Dec 31, 2024	1.04B	-327.89M	-24.01%
Dec 31, 2023	1.37B	-293.30M	-17.68%
Dec 31, 2022	1.66B	491.67M	42.12%
Dec 31, 2021	1.17B	501.31M	75.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error